ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
DelMar Pharmaceuticals Inc

DelMar Pharmaceuticals Inc (DMPI)

1.34
0.00
( 0.00% )
Updated: 19:00:00

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -4.65M-3.5M-3.3M-3.35M-2.96M-1.02M-2.09M-2.39M
Pre Tax Income -4.6M-3.45M-3.26M-3.34M-2.96M-1.02M-2.01M-2.32M
Net Income -4.6M-3.45M-3.63M-3.34M-3.14M-1.03M-2.01M-2.33M
Preferred Dividends 00-368k-2k-175k-2k-2k-2k
Basic Earnings Per Share (EPS) 00000000
EBIT -4.65M-3.5M-3.3M-3.35M-2.96M-1.02M-2.09M-2.39M
EBITDA -4.63M-3.48M-3.29M-3.33M-2.95M-1M-2.08M-2.37M
Year End June 29 2024 20172018201920202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -8.32M-11.17M-8.4M-9.2M-38.17M-22.68M-14.8M-8.45M
Pre Tax Income -8.08M-11.14M-8.05M-9.13M-38.3M-22.66M-14.65M-8.32M
Net Income -8.87M-11.32M-8.13M-9.14M-41.5M-22.66M-15.02M-8.5M
Preferred Dividends -790k-177k-81k-9k-3.21M0-370k-181k
Basic Earnings Per Share (EPS) -0.611-0.493-2.117-0.797-1.268-0.346-8.876-0.154
EBIT -8.32M-11.17M-8.4M-9.2M-38.26M-22.68M-14.8M-8.45M
EBITDA -8.3M-11.15M-8.38M-9.19M-22.04M-22.62M-14.74M-8.4M

Your Recent History

Delayed Upgrade Clock